Tesla asks court to throw out damages awarded in deadly crash — claim Musk misled jury

Tesla is seeking to overturn or significantly reduce a $243 million jury award in a fatal crash case, arguing plaintiff lawyers misled the jury and introduced prejudicial evidence. The jury had found Tesla partially responsible due to faulty Autopilot technology, despite the driver being primarily at fault. This verdict, which Tesla claims chills innovation and creates undue liability, carries significant implications for the autonomous vehicle industry's future liability landscape and Tesla's stock, which fell nearly 3.5% Friday amid broader sales and regulatory challenges.

Analysis

Tesla is legally challenging a $243 million jury award from a fatal 2019 crash, a case with significant implications for the company and the broader autonomous vehicle sector. The verdict established partial liability for Tesla due to faulty Autopilot technology, even though the driver was found primarily at fault for speeding and being distracted. This outcome sets a critical legal precedent, potentially increasing liability risks for all automakers developing driver-assist features. The company's decision to refuse a $60 million settlement offer, resulting in a verdict four times that amount, indicates a substantial legal and financial misjudgment. This litigation pressure is compounded by wider regulatory scrutiny over its 'Autopilot' and 'Full-Self Driving' branding in both the U.S. and Europe, which authorities argue could mislead drivers. The negative news flow contributed to a nearly 3.5% drop in TSLA's stock, a decline also fueled by reports of weakening European sales, illustrating a confluence of legal, regulatory, and fundamental challenges facing the company.

Key Decisions for Investors

• Investors should closely monitor the outcome of Tesla's legal appeal and parallel regulatory challenges, as these could set costly precedents for the entire autonomous vehicle industry's liability framework.
• The rejection of a $60 million settlement offer, leading to a $243 million award, raises questions about management's risk assessment and may warrant a higher risk premium on the stock.
• The stock's 3.5% decline reflects a confluence of factors beyond this single verdict, including weakening European demand, so any investment thesis must account for both legal overhangs and deteriorating business fundamentals.